Velpanat Tablet

Velpanat Tablet Specification

Salt Composition
Sofosbuvir (400mg) + Velpatasvir (100mg)

Indication
Chronic Hepatitis C virus (HCV) infection

Origin
India

Dosage Form
Tablet

Enzyme Types
Velpanat Tablet

Feature
Fixed-dose combination, broad genotype coverage, once-daily dose

Ingredients
Sofosbuvir, Velpatasvir, Excipients

Application
Antiviral medication for Hepatitis C

Physical Color/Texture
Light blue, film-coated, oval-shaped tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits HCV NS5A and NS5B replication complexes

Storage Instructions
Cool & Dry Place

Shelf Life
24-36 months (as per manufacturer specifications)

Marketed By
Natco Pharma Ltd.

Packaging Type
Bottle or blister pack (typically 28 tablets per bottle)

Country of Approval
Approved in India (consult local regulations elsewhere)

Contraindications
Hypersensitivity to active substances

Side Effects
Headache, fatigue, nausea, insomnia

Prescription Required
Yes

ATC Code
J05AP55

Warning
To be used under medical supervision only

Drug Class
Direct-acting antiviral (DAA) agents

Patient Age Group
Adults (Consult physician for pediatric use)

Administration Route
Oral

Velpanat Tablet Trade Information

Minimum Order Quantity
10 Bottles

Supply Ability
100 Bottles Per Day

Delivery Time
2 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Velpanat Tablet

Velpanat Tablet

He simple treatment by VELPANAT (Velpatasvir 100mg Sofosbuvir 400mg) is effective for the patients in the broader range and these are the patients who have the chronic Hepatitis C infection also known as the HCV. This particular drug has the nucleotide polymerase inhibitor associated with it that plays a major role in the treatment and if the patient takes VELPANAT for a period of 12 weeks at a stretch, it will provide amazing rate of sustained virologic response for the patients having the HCV infections of the genotypes 1, 2, 3, 4, 5 or 6. You can use VELPANAT either alone or you can also use it with ribavirin for the treatment of Hepatitis C. This drug falls in the category of antiviral medications called the NS5B polymerase inhibitors and replication complex inhibitors. This drug stops the virus that is the cause of the spread of HCV in the body of the patient. The tablet of VELPANAT can take it with or without food. It is important to take this particular medicine at the same time on a daily basis and the person has to follow the directions as provided by Hepatologist or HCV treatment specialist in the prescription label.

Comprehensive HCV Treatment

Velpanat offers a potent antiviral solution for chronic Hepatitis C, using a combination of sofosbuvir and velpatasvir. Its broad genotype activity ensures effectiveness across diverse patient populations, making it a trusted option in comprehensive hepatitis therapy.

Convenient Dosage and Administration

Designed for patient convenience, Velpanat requires just a once-daily oral tablet. The treatment regimen, typically 12 weeks, is straightforward and can be managed at home, provided regular guidance from your healthcare provider.

Strict Medical Supervision and Safety

Velpanat is only available by prescription and must be used under the supervision of a qualified healthcare professional. Important safety considerations include potential side effects like headache, fatigue, nausea, and hypersensitivity in some individuals.

FAQ's of Velpanat Tablet:

Q: How should Velpanat Tablet be administered for chronic Hepatitis C?

A: Velpanat Tablet should be taken orally once daily, with or without food, as directed by your physician. Consistent daily intake is crucial for effective treatment outcomes. Do not stop or alter the dosage without consulting your healthcare provider.

Q: What are the main benefits of using Velpanat for Hepatitis C?

A: Velpanat offers high efficacy across all major HCV genotypes, convenient once-daily dosing, and a favorable safety profile, making it a comprehensive and reliable option for adult patients with chronic Hepatitis C.

Q: When is Velpanat contraindicated?

A: Velpanat should not be used by individuals with known hypersensitivity to sofosbuvir, velpatasvir, or any excipients in the formulation. Always consult your physician to assess suitability if you have a history of drug allergies.

Q: Where is Velpanat approved and who supplies it?

A: Velpanat is approved for use in India and should only be obtained through a licensed pharmacy or authorized supplier. Natco Pharma Ltd. is the manufacturer and marketer of this medication.

Q: What precautions should patients take during Velpanat therapy?

A: Patients should use Velpanat strictly under medical supervision. Report any side effects such as headache, fatigue, nausea, or insomnia to your doctor. The medication should be stored in a cool, dry place and kept out of reach of children.

Q: What is the process for obtaining Velpanat tablets?

A: A valid prescription from a qualified healthcare provider is required to obtain Velpanat. The tablets are supplied in bottles or blister packs, typically containing 28 tablets, from licensed pharmacies or healthcare distributors in India.

Q: Can Velpanat be used by children or pregnant women?

A: Velpanat is indicated for adult patients. Its use in pediatric or pregnant populations should only be considered under strict guidance and evaluation by a healthcare professional.

Tell us about your requirement